Concepedia

Publication | Open Access

Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance

23

Citations

38

References

2013

Year

Abstract

We identified a promising pyrazolo[1,5-a]pyrimidine compound devoid of ABC transporter interaction, highly suitable for further preclinical and clinical evaluation for the treatment of cancer.

References

YearCitations

Page 1